Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protectionEmma S. Winkler, Michael Diamond, Rita E. Chen et al.|Cell|2021Cited by 392
Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions and monocytes for optimal therapeutic protectionEmma S. Winkler, Michael Diamond, Pavlo Gilchuk et al.|bioRxiv (Cold Spring Harbor Laboratory)|2020Cited by 44